SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-014475
Filing Date
2020-08-03
Accepted
2020-08-03 16:16:42
Documents
74
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 452419
2 ex31-1.htm EX-31.1 18728
3 ex31-2.htm EX-31.2 18667
4 ex32-1.htm EX-32.1 6760
5 ex32-2.htm EX-32.2 6934
  Complete submission text file 0001493152-20-014475.txt   2955790

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE xtnt-20200630.xml EX-101.INS 442666
7 XBRL SCHEMA FILE xtnt-20200630.xsd EX-101.SCH 44862
8 XBRL CALCULATION FILE xtnt-20200630_cal.xml EX-101.CAL 64628
9 XBRL DEFINITION FILE xtnt-20200630_def.xml EX-101.DEF 107258
10 XBRL LABEL FILE xtnt-20200630_lab.xml EX-101.LAB 293185
11 XBRL PRESENTATION FILE xtnt-20200630_pre.xml EX-101.PRE 214085
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34951 | Film No.: 201069432
SIC: 2836 Biological Products, (No Diagnostic Substances)